drugset / Trial / NCT00250458

Study to Test a Marketed Product in the Treatment of Migraine-associated Nausea

NCT00250458

Phase 3 Completed 346 enrolled Organon and Co
RandomizedParallel-groupDouble-blindTreatment

Summary

Study to test the effectiveness of a marketed drug in the treatment of migraine-associated nausea.

Timeline

Start
2006-03
Primary completion
2006-10
Completion
2006-10

Drugs

EvaluationDrugModalityDoseRoute
Subject rizatriptan Unknown 10 mg Oral

Indications